These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29076382)

  • 1. Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.
    Nuvolone M; Merlini G
    Expert Opin Ther Targets; 2017 Dec; 21(12):1095-1110. PubMed ID: 29076382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis.
    Obici L; Merlini G
    Expert Opin Investig Drugs; 2014 Sep; 23(9):1239-51. PubMed ID: 25003808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic amyloidosis: novel therapies and role of biomarkers.
    Nuvolone M; Merlini G
    Nephrol Dial Transplant; 2017 May; 32(5):770-780. PubMed ID: 27540044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis.
    Comenzo RL
    Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloidosis.
    Pinney JH; Hawkins PN
    Ann Clin Biochem; 2012 May; 49(Pt 3):229-41. PubMed ID: 22402917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and treatment of systemic amyloidosis.
    Gillmore JD; Hawkins PN
    Nat Rev Nephrol; 2013 Oct; 9(10):574-86. PubMed ID: 23979488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amyloidosis: a model of misfolded protein disorder].
    Grateau G; Verine J; Delpech M; Ries M
    Med Sci (Paris); 2005; 21(6-7):627-33. PubMed ID: 15985206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trials evaluating potential therapies for light chain (AL) amyloidosis.
    Muchtar E; Gertz MA
    Expert Opin Orphan Drugs; 2017; 5(8):655-663. PubMed ID: 34567849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy in systemic primary (AL) amyloidosis using amyloid-reactive monoclonal antibodies.
    Solomon A; Weiss DT; Wall JS
    Cancer Biother Radiopharm; 2003 Dec; 18(6):853-60. PubMed ID: 14969598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic amyloidosis: are we moving ahead?
    Merlini G
    Neth J Med; 2004 Apr; 62(4):104-5. PubMed ID: 15255078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of amyloid formation.
    Härd T; Lendel C
    J Mol Biol; 2012 Aug; 421(4-5):441-65. PubMed ID: 22244855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y
    J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug development for cancer chemoprevention: focus on molecular targets.
    Johnson KA; Brown PH
    Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment in systemic amyloidosis].
    Ikeda S
    Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs in clinical development for the treatment of amyotrophic lateral sclerosis.
    Martinez A; Palomo Ruiz MD; Perez DI; Gil C
    Expert Opin Investig Drugs; 2017 Apr; 26(4):403-414. PubMed ID: 28277881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging Advances in the Management of Cardiac Amyloidosis.
    Vranian MN; Sperry BW; Valent J; Hanna M
    Curr Cardiol Rep; 2015 Nov; 17(11):100. PubMed ID: 26374453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational drugs for pruritus.
    Benecke H; Lotts T; Ständer S
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1167-79. PubMed ID: 23815605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational drugs in systemic vasculitis.
    Mirouse A; Cacoub P; Desbois AC; Comarmond C; Pagnoux C; Saadoun D
    Expert Opin Investig Drugs; 2017 Sep; 26(9):1049-1061. PubMed ID: 28758504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.